Johns Hopkins ABX Guide
Eravacycline
INDICATIONS
FDA
FDA
- Management of complicated intra-abdominal infections (cIAI)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: February 5, 2019
Citation
Dzintars, Kathryn. "Eravacycline." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540702/all/Eravacycline.
Dzintars K. Eravacycline. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540702/all/Eravacycline. Accessed October 31, 2025.
Dzintars, K. (2019). Eravacycline. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540702/all/Eravacycline
Dzintars K. Eravacycline [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2025 October 31]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540702/all/Eravacycline.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Eravacycline
ID - 540702
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2019/02/05/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540702/all/Eravacycline
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
